|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 7/00 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 7/08 | (2006.01) | ||
| C12Q 1/37 | (2006.01) | ||
| G01N 33/569 | (2006.01) |
| (11) | Number of the document | 2236608 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10003191.3 |
| Date of filing the European patent application | 2006-10-04 | |
| (97) | Date of publication of the European application | 2010-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
| (46) | Date of publication of the claims translation | 2017-03-27 |
| (30) | Number | Date | Country code |
| 722962 P | 2005-10-04 | US | |
| 722958 P | 2005-10-04 | US | |
| 722959 P | 2005-10-04 | US |
| (72) |
Donini, Oreola, CA
Rozek, Annett, CA
Lentz, Shannon, Wayne, CA
|
| (73) |
Soligenix, Inc.,
29 Emmons Drive, Suite C-10, Princeton, NJ 08540,
US
|
| (74) |
Valters GENCS,
J. Basanavičiaus g. 26, Vilnius,
LT
|
| (54) | Naujieji peptidai, skirti gydymui ir prevencijai su imunitetu susijusių sutrikimų, įskaitant infekcijų gydymą ir prevenciją, moduliuojant įgimtą imunitetą |
| Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| Payment date | Validity (years) | Amount | |
| 2025-09-18 | 20 | 347.00 EUR |